Latest Articles
- Hold ACE inhibitors and ARBs before noncardiac surgery? Emerging evidence suggests a patient-specific approach
Judicious withholding of ACE inhibitors and ARBs in vulnerable populations—and promptly resuming them—may strike the safest balance between renal protection and hemodynamic stability.
- Do patients with severe community-acquired bacterial pneumonia benefit from systemic corticosteroids?
Recent evidence has swung the pendulum back in favor of using corticosteroids in patients with severe community-acquired pneumonia.
Low-dose colchicine for management of coronary artery diseaseCurrent guidelines endorse adding low-dose colchicine to standard medical therapy for coronary artery disease prevention, but data show clinicians remain hesitant to use it for this indication.
- No surprise, all inflammation is not created equal as it relates to cardiovascular disease
It is accepted that inflammation is an important component of atherosclerotic cardiovascular disease, but have we found the right inflammatory target for pharmacologic therapy?
- How can I help my pregnant patients quit using tobacco?
Clinicians should screen for tobacco use and follow-up with pregnancy-specific messaging during each visit, building on any motivation the patient has to quit.
- What is the role of cystatin C in estimating glomerular filtration rate and guiding medication dosing?
A dual-marker strategy using both serum creatinine and cystatin C is recommended for certain patients in whom serum creatinine alone may not accurately reflect kidney function.
- Optimizing hypertension treatment: Evidence-based approaches and new drugs
The authors discuss current evidence-based approaches to managing hypertension and optimizing blood pressure control through a series of cases representing common clinical scenarios.
